NONLINEAR PHARMACOKINETICS OF 5-FLUOROURACIL AS DESCRIBED BY INVIVO BEHAVIOR OF 5,6 DIHYDRO-5-FLUOROURACIL

被引：24

作者：

DEBRUIJN, EA ^{[1
]}

REMEYER, L ^{[1
]}

TJADEN, UR ^{[1
]}

ERKELENS, C ^{[1
]}

DEBRAUW, LM ^{[1
]}

VANDEVELDE, CJH ^{[1
]}

机构：

[1] SYLVIUS LABS,DEPT CLIN ONCOL,2333 AL LEIDEN,NETHERLANDS

来源：

BIOCHEMICAL PHARMACOLOGY | 1986年 / 35卷 / 15期

关键词：

D O I：

10.1016/0006-2952(86)90041-9

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：2461 / 2465

页数：5

共 16 条

[1]

AUBERT C, 1981, B CANCER, V68, P343

[2]

CHAUDHURI NK, 1958, CANCER RES, V18, P318

[3]

CHAUDHURI NK, 1958, BIOCHEM PHARMACOL, V1, P328

[4] NON-LINEAR PHARMACOKINETIC MODELS FOR 5-FLUOROURACIL IN MAN - INTRAVENOUS AND INTRAPERITONEAL ROUTES [J].

COLLINS, JM ;

DEDRICK, RL ;

KING, FG ;

SPEYER, JL ;

MYERS, CE .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 28 (02) :235-246

[5]

DEBRUIJN EA, 1985, CANCER RES, V45, P5931

[6] A GAS-CHROMATOGRAPHIC ASSAY FOR THE DETERMINATION OF 5,6-DIHYDROFLUOROURACIL AND 5-FLUOROURACIL IN HUMAN-PLASMA [J].

DEBRUIJN, EA ;

DRIESSEN, O ;

VANDENBOSCH, N ;

VANSTRIJEN, E ;

SLEE, PHTJ ;

VANOOSTEROM, AT ;

TJADEN, UR .

JOURNAL OF CHROMATOGRAPHY, 1983, 278 (02) :283-289

[7]

DEBRUIN EA, 1983, J CHROMATOGR, V279, P603

[8]

DIASIO RB, 1985, CANCER RES, V45, P4900

[9]

HEIDELBERGER C, 1974, HDB EXPTL PHARMACO 2, V38, P193

[10] NON-LINEAR PHARMACOKINETICS FOR THE ELIMINATION OF 5-FLUOROURACIL AFTER INTRAVENOUS ADMINISTRATION IN CANCER-PATIENTS [J].

MCDERMOTT, BJ ;

VANDENBERG, HW ;

MURPHY, RF .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1982, 9 (03) :173-178

← 1 2 →